Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1996 May 28;93(11):5191-6.
doi: 10.1073/pnas.93.11.5191.

Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor

Affiliations

Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor

H W Sun et al. Proc Natl Acad Sci U S A. .

Abstract

Macrophage migration inhibitory factor (MIF) was the first cytokine to be described, but for 30 years its role in the immune response remained enigmatic. In recent studies, MIF has been found to be a novel pituitary hormone and the first protein identified to be released from immune cells on glucocorticoid stimulation. Once secreted, MIF counterregulates the immunosuppressive effects of steroids and thus acts as a critical component of the immune system to control both local and systemic immune responses. We report herein the x-ray crystal structure of human MIF to 2.6 angstrom resolution. The protein is a trimer of identical subunits. Each monomer contains two antiparallel alpha-helices that pack against a four-stranded beta-sheet. The monomer has an additional two beta-strands that interact with the beta-sheets of adjacent subunits to form the interface between monomers. The three beta-sheets are arranged to form a barrel containing a solvent-accessible channel that runs through the center of the protein along a molecular 3-fold axis. Electrostatic potential maps reveal that the channel has a positive potential, suggesting that it binds negatively charged molecules. The elucidated structure for MIF is unique among cytokines or hormonal mediators, and suggests that this counterregulator of glucocorticoid action participates in novel ligand-receptor interactions.

PubMed Disclaimer

References

    1. Cell. 1992 May 1;69(3):425-37 - PubMed
    1. Mol Med. 1996 Jan;2(1):143-9 - PubMed
    1. J Mol Biol. 1992 Sep 20;227(2):493-509 - PubMed
    1. Biochemistry. 1992 Oct 27;31(42):10169-84 - PubMed
    1. Nature. 1992 Nov 19;360(6401):269-70 - PubMed

Publication types

MeSH terms

Substances